AI MARKET SCANNING

Genprex Inc

📅 Next Catalyst: Nov 12, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.04%
MAX GAP RECORD -5.74%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $GNPX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 14, 2026 Earnings Release 2026-08-14 (AFTER CLOSE)
-2.78%
Apr 01, 2025 Earnings Release 2025-04-01 (BEFORE OPEN)
+1.63%
Nov 13, 2024 Earnings Release 2024-11-13 (BEFORE OPEN)
-5.74%
Aug 09, 2024 Earnings Release 2024-08-09 (AFTER CLOSE)
+4.93%
Apr 02, 2024 Earnings Release 2024-04-02 (AFTER CLOSE)
+1.76%
Mar 31, 2023 Earnings Release 2023-03-31 (AFTER CLOSE)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.4%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $GNPX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗